• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2776206
  • March 2014
  • Region: Global
  • 102 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Affymetrix, Inc.
  • bioMerieux, Inc.
  • F. Hoffman-La Roche, Ltd.
  • Gen-Probe, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • MORE

'Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing.

The market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer’s disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Affymetrix, Inc.
  • bioMerieux, Inc.
  • F. Hoffman-La Roche, Ltd.
  • Gen-Probe, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation: Multiplexed Diagnostics Market
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Multiplexed Diagnostics Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.1.1 Global Multiplexed Assay Market Revenue, 2011 – 2019 (USD Million)
3.2 Drivers
3.2.1 Completion of the Human Genome Project
3.2.2 Increasing Prevalence of Cancer and Infectious Diseases
3.2.3 Multiple Usage
3.2.4 Evolving Regulatory landscape
3.3 Restraints
3.3.1 Costly Equipment
3.3.2 Lack of skilled labour
3.3.3 Lack of Reimbursement Coverage
3.4 Opportunities
3.4.1 Automation of the Multiplexed Diagnostic Instrument
3.4.2 Development Of Generic Platforms
3.5 Porter’s Five Force Analysis for the Global Multiplexed Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of Multiplexed Assay Market, by Geography

Chapter 4 Global Multiplex Assays Market, by Technology
4.1 Overview – Current Market Scenario and Future Market Trends
4.2 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology, 2012 & 2019 (Value %)
4.3 Very High Density Multiplexed Assays (> 10,000-plex)
4.3.1 Global Very High Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million)
4.3.2 Oligonucleotide Arrays
4.3.3 Phage Display
4.4 High Density Multiplexed Assays (500 = plex = 10,000)
4.4.1 Global High Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million)
4.4.2 Bacterial Artificial Chromosome Arrays
4.4.3 Protein Arrays
4.5 Medium Density Multiplexed Assays (plex < 500)
4.5.1 Global Medium Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
4.5.2 Bead-based Arrays
4.5.3 Antibody Arrays
4.5.4 Reverse Arrays
4.5.5 Mass Spectrometry
4.6 Low Density Multiplexed Assays (plex = 5)
4.6.1 Global Low Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million)
4.6.2 Quantitative PCR Bead-based
4.6.3 Microplate Assays
4.7 Next-Generation Sequencing Assays
4.7.1 Global Next Generation Sequencing Market Revenue, 2011 – 2019, (USD Million)

Chapter 5 Global Multiplex Diagnostics Market, By Application
5.1 Overview – Current Market Scenario and Future Market Trends
5.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application, 2012 & 2019 (Value %)
5.2 Infectious Disease Diagnosis
5.2.1 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.3 Oncology
5.3.1 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.4 Autoimmune diseases
5.4.1 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.5 Cardiac
5.5.1 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.6 Allergies
5.6.1 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.7 Others
5.7.1 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 – 2019, (USD Million)

Chapter 6 Global Multiplexed Diagnostics Market, by Geography
6.1 Introduction
6.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %)
6.2 North America
6.2.1 North America Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Market Strategies for Success
7.1.1 Innovation in Technology
7.1.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Affymetrix, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.4.1 Diversified Product Portfolio
8.1.4.2 Partnerships
8.1.5 Recent Developments
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.4.1 Acquisitions
8.2.4.2 Expansion into Emerging Markets
8.2.5 Recent Developments
8.3 bioMerieux, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.4.1 Acquisitions
8.3.4.2 Expansion
8.3.4.3 Partnerships and Collaborations
8.3.5 Recent Developments
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.4.1 Mergers and Acquisitions
8.4.4.2 Partnership
8.4.5 Recent Developments
8.5 Illumina, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.4.1 Strategic Acquisitions
8.5.4.2 Expansion
8.5.4.3 Partnership
8.5.5 Recent Developments
8.6 F. Hoffman-La Roche, Ltd.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Gen-Probe, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.4.1 Expansion
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Business Strategies
8.8.3.1 Partnerships and Collaborations
8.8.4 Recent Developments
8.9 Luminex Corporation
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.4.1 Diversified Product Portfolio
8.9.4.2 Partnerships
8.9.5 Recent Developments
8.10 Seegene, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments

List of Figures

FIG. 1 Multiplexed Diagnostics Market Segmentation
FIG. 2 Global Multiplexed Diagnostics Market Revenue, by Technology, 2012 (USD Million)
FIG. 3 Global Multiplexed Diagnostics Market Revenue, by Geography, 2012 (USD Million)
FIG. 4 Global Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 5 Porter’s Five Force Analysis: Global Multiplexed Diagnostics Market
FIG. 6 Market Attractiveness Analysis of Global Multiplexed Diagnostics Market, by Geography
FIG. 7 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology, 2012 & 2019 (Value %)
FIG. 8 Global Very High Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global High Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Medium Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Low Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Next Generation Sequencing Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application, 2012 & 2019 (Value %)
FIG. 14 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %)
FIG. 21 North America Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 22 Europe Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 23 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 25 Affymetrix, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 Agilent Technologies, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 bioMerieux, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Illumina, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 F. Hoffman-La Roche, Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Gen-Probe, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Life Technologies Corporation, Annual Revenue, 2010 – 2012 (USD Million)
FIG. 33 Luminex Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Seegene, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Multiplexed Diagnostics Market
TABLE 3 Global Multiplexed Diagnostics Market Revenue, by Technology 2011 – 2019 (USD Million)
TABLE 4 Global Multiplexed Diagnostics Market Revenue, by Application, 2011 – 2019 (USD Million)
TABLE 5 Global Multiplexed Diagnostics Market Revenue, by Geography, 2011 – 2019 (USD Million)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Affymetrix, Inc.
  • bioMerieux, Inc.
  • F. Hoffman-La Roche, Ltd.
  • Gen-Probe, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • MORE

Multiplexed diagnostics are assays that are capable of analyzing multiple analytes in the single cycle of the assay procedure. These tools are evolved from diagnostic assays that screens single analyte in single run of the assay procedure and are used in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedure to screen multiple analytes. In diagnostics market, multiplexed assays are used in clinical laboratories and hospitals for the diagnosis of various diseases and disorders. Multiplexed assays are used for diagnosis of infectious diseases, cancer biomarkers, cardiac diseases, allergies and autoimmune diseases.

Multiplexed diagnostics techniques include very high density multiplexed assays, high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays and next-generation sequencing. All the technologies used in multiplexing are based on the principle of screening of multiple analytes in single cycle of the assay. Very high density multiplexed assays include oligonucleotide arrays and phage display. High density multiplexed assays include bacterial artificial chromosome arrays and protein arrays. Medium density multiplexed assays include bead-based arrays, antibody assays, reverse assays and mass spectroscopy. Low density multiplexed assays include qPCR bead-based assays and microplate assays.

Currently, medium density multiplexed assay market leads the overall multiplexed diagnostics market and is followed by low density multiplexed diagnostics assays. Bead-based arrays and antibody arrays is the most preferred multiplexed technique. Medium density arrays market is dominating the industry due to its multiple applications in other technologies used in the multiplexed diagnostics. For instance, bead-based assays used in combination with immunoassays and oligonucleotides in combination with protein assays. The cost of medium density multiplexed assays is lesser as compared to very high density and high density multiplexed assays thus resulting in added affordability and thereby growth in demand in emerging economies.

The global multiplexed diagnostics market is highly consolidated in nature. Bigger market players lead this market with their proprietary products and robust development strategies. Established players in the market follow the trend of large scale union and collaborative activities such as supply agreements, acquisitions and partnerships to expand their market share. Intensive competitive rivalry exists in the market as a result of price competition due to the presence of limited market players in the industry.

Geographically, North America is leading the global multiplexed diagnostics market. Highly developed healthcare infrastructure, developed technology and high rates of adoption are some of the major factors that are driving the growth of multiplexed diagnostics market in the North America. Asia-Pacific is the lucrative market for multiplexed diagnostics market owing to rapidly growing medical industry in the region. In addition, Asia-Pacific covers more than 50% of the global population and demonstrates the highest rates of morbidity of infectious diseases and cardiac diseases in this region. Japan is currently the most dominant market in the Asia-Pacific region and is followed by China and India. Government initiatives to create awareness about the available diagnostic procedures and research activities to boost the biotechnology industry in the respective countries will further augment the growth of multiplexed diagnostics market in emerging economies.

Note: Product cover images may vary from those shown

- Affymetrix, Inc.
- Agilent Technologies, Inc.
- bioMerieux, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- F. Hoffman-La Roche, Ltd.
- Gen-Probe, Inc.
- Life Technologies Corporation
- Luminex Corporation
- Seegene, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos